The Clinical Outcome of Patients with Refractory/Relapsed Lymphoid Blastic Phase of Chronic Myeloid Leukemia Treated with CAR T-Cells Therapy

被引：0
|
作者：
Liu, Yujie [1 ,2 ]
Tu, Yuqing [1 ,2 ]
Xiao, Jinyan [1 ,2 ]
Shen, Yifan [2 ]
Zhou, Biqi [1 ,2 ]
Yang, Qiannan [1 ,2 ]
Liu, Tianhui [1 ,2 ]
Qi, Lijuan [1 ,2 ]
Chen, Jia [1 ,2 ]
Yu, Lei [3 ]
Wu, Depei [1 ,2 ]
Yang, Xu [1 ,2 ]
机构：
[1] Inst Blood & Marrow Transplantat, Collaborat Innovat Ctr Hematol, Suzhou, Peoples R China
[2] Soochow Univ, Affiliated Hosp 1, Natl Clin Res Ctr Hematol Dis, Jiangsu Inst Hematol, Suzhou, Peoples R China
[3] Shanghai Unicar Therapy Biomed Technol Co Ltd, Shanghai, Peoples R China
来源：
BLOOD | 2023年 / 142卷
关键词：
D O I：
10.1182/blood-2023-190741
中图分类号：
R5 [内科学];
学科分类号：
1002 ; 100201 ;
摘要：
引用
收藏
页数：3
相关论文
共 50 条
  • [31] Sudden blastic transformation in patients with chronic myeloid leukemia treated with imatinib mesylate
    Jabbour, E
    Kantarjian, H
    O'Brien, S
    Rios, MB
    Abruzzo, L
    Verstovsek, S
    Garcia-Manero, G
    Cortes, J
    BLOOD, 2006, 107 (02) : 480 - 482
  • [32] Bosutinib as a fourth-line therapy for a patient with T315I-positive lymphoid blastic phase chronic myeloid leukemia: A case report
    Komeno, Yukiko
    Uchida, Naoyuki
    Satoh, Yumiko
    Uryu, Hideki
    Iwata, Yuko
    Masuda, Akiko
    Iihara, Kuniko
    Yatomi, Yutaka
    Taniguchi, Shuichi
    Ryu, Tomiko
    ONCOLOGY LETTERS, 2017, 13 (06) : 4285 - 4289
  • [33] Prognostic Significance of Regulatory T-Cells and PD-1+CD8 T-Cells in Chronic Myeloid Leukemia Patients Treated with Generic Imatinib
    Saj, Fen
    Nampoothiri, Ram Vasudevan
    Lad, Deepesh
    Jandial, Aditya
    Sachdeva, Man Updesh Singh
    Bose, Parveen
    Varma, Neelam
    Khadwal, Alka
    Prakash, Gaurav
    Malhotra, Pankaj
    INDIAN JOURNAL OF HEMATOLOGY AND BLOOD TRANSFUSION, 2024, 40 (04) : 580 - 587
  • [34] Outcome of Chronic Myeloid Leukemia-Chronic Phase Patients Treated With Imatinib: A Local Experience
    Al-Amri, Ali M.
    CLINICAL LYMPHOMA MYELOMA & LEUKEMIA, 2018, 18 (03): : 199 - 203
  • [35] Naturally Selected CD7-Targeted Chimeric Antigen Receptor (CAR)-T Cell Therapy for Refractory/Relapsed Acute Myeloid Leukemia: Phase I Clinical Trial
    Xian Zhang
    Junfang Yang
    Jingjing Li
    Liyuan Qiu
    Liu Hongxing, Sr.
    Min Xiong
    Jianqiang Li
    Peihua Lu
    BLOOD, 2023, 142
  • [36] What happens to intolerant, relapsed or refractory chronic myeloid leukemia patients without access to clinical trials?
    Bosi, Guilherme Rasia
    Fogliatto, Laura Maria
    Costa, Tito Emilio Vanelli
    Grokoski, Kamila Castro
    Pereira, Mariana Pinto
    Bugs, Nathan
    Kalil, Marco
    Fraga, Christina
    Daudt, Liane Esteves
    Silla, Lucia Mariano da Rocha
    HEMATOLOGY TRANSFUSION AND CELL THERAPY, 2019, 41 (03) : 222 - 228
  • [37] CHRONIC MYELOID-LEUKEMIA ARISING IN A PROGENITOR COMMON TO T-CELLS AND MYELOID CELLS
    SCHUH, AC
    SUTHERLAND, DR
    HORSFALL, W
    MILLS, GB
    DUBE, I
    BAKER, MA
    SIMINOVITCH, K
    BAILEY, D
    KEATING, A
    LEUKEMIA, 1990, 4 (09) : 631 - 636
  • [38] A Phase I Study of Fludarabine, Cytarabine, and Oxaliplatin Therapy in Patients With Relapsed or Refractory Acute Myeloid Leukemia
    Tsimberidou, Apostolia Maria
    Keating, Michael J.
    Jabbour, Elias J.
    Ravandi-Kashani, Farhad
    O'Brien, Susan
    Estey, Elihu
    Bekele, Neby
    Plunkett, William K., Jr.
    Kantarjian, Hagop
    Borthakur, Gautam
    CLINICAL LYMPHOMA MYELOMA & LEUKEMIA, 2014, 14 (05): : 395 - 400
  • [39] Similar Outcome of Patients With Chronic Myeloid Leukemia Treated With Imatinib in or Out of Clinical Trials
    Yilmaz, Musa
    Kantarjian, Hagop
    Jabbour, Elias
    O'Brien, Susan
    Borthakur, Gautam
    Verstovsek, Srdan
    Garcia-Manero, Guillermo
    Ravandi, Farhad
    Burger, Jan
    Pierce, Sherry
    Quintas-Cardama, Alfonso
    Cortes, Jorge
    CLINICAL LYMPHOMA MYELOMA & LEUKEMIA, 2013, 13 (06): : 693 - 699
  • [40] Clinical and cytologic characteristics of blastic phase in Ph-positive chronic myeloid leukemia treated with alpha-interferon
    Alimena, G
    Lazzarino, M
    Morra, E
    Mancini, M
    Cedrone, M
    Montefusco, E
    Merante, S
    Meloni, G
    Bernasconi, P
    Rondinelli, MB
    Bernasconi, C
    Mandelli, F
    LEUKEMIA, 1996, 10 (04) : 615 - 618
12345